1. Home
  2. YJ vs GLTO Comparison

YJ vs GLTO Comparison

Compare YJ & GLTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YJ
  • GLTO
  • Stock Information
  • Founded
  • YJ 2015
  • GLTO 2011
  • Country
  • YJ China
  • GLTO Denmark
  • Employees
  • YJ N/A
  • GLTO N/A
  • Industry
  • YJ Other Specialty Stores
  • GLTO Biotechnology: Pharmaceutical Preparations
  • Sector
  • YJ Consumer Discretionary
  • GLTO Health Care
  • Exchange
  • YJ Nasdaq
  • GLTO Nasdaq
  • Market Cap
  • YJ 8.8M
  • GLTO 6.5M
  • IPO Year
  • YJ 2019
  • GLTO 2020
  • Fundamental
  • Price
  • YJ $1.73
  • GLTO $4.82
  • Analyst Decision
  • YJ
  • GLTO Buy
  • Analyst Count
  • YJ 0
  • GLTO 1
  • Target Price
  • YJ N/A
  • GLTO $10.00
  • AVG Volume (30 Days)
  • YJ 37.2K
  • GLTO 18.1K
  • Earning Date
  • YJ 03-20-2025
  • GLTO 03-07-2025
  • Dividend Yield
  • YJ N/A
  • GLTO N/A
  • EPS Growth
  • YJ N/A
  • GLTO N/A
  • EPS
  • YJ N/A
  • GLTO N/A
  • Revenue
  • YJ $66,957,730.00
  • GLTO N/A
  • Revenue This Year
  • YJ N/A
  • GLTO N/A
  • Revenue Next Year
  • YJ N/A
  • GLTO N/A
  • P/E Ratio
  • YJ N/A
  • GLTO N/A
  • Revenue Growth
  • YJ N/A
  • GLTO N/A
  • 52 Week Low
  • YJ $1.42
  • GLTO $4.24
  • 52 Week High
  • YJ $4.72
  • GLTO $23.50
  • Technical
  • Relative Strength Index (RSI)
  • YJ 49.01
  • GLTO 46.33
  • Support Level
  • YJ $1.65
  • GLTO $4.24
  • Resistance Level
  • YJ $1.78
  • GLTO $4.65
  • Average True Range (ATR)
  • YJ 0.12
  • GLTO 0.31
  • MACD
  • YJ -0.01
  • GLTO -0.01
  • Stochastic Oscillator
  • YJ 28.57
  • GLTO 51.81

About YJ Yunji Inc. American Depository Shares

Yunji Inc is a social e-commerce platform in China that offers a membership-based model that leverages the power of social interaction. The company provides a host of selected commodities such as beauty and personal care, mobile phones and digital products, baby and maternal products, toys, fruits, and other fresh products. It has expanded to operate its business, including the marketplace, on a diverse range of sales channels and other platforms. Geographically, the firm operates in China.

About GLTO Galecto Inc.

Galecto Inc is a clinical-stage biotechnology company developing therapeutics designed to target the biological processes that lie at the heart of fibrosis and impact a broad range of fibrotic and related diseases, including cancer. Its initial focus is on the development of small-molecule inhibitors of galectin-3 and lysyl oxidase-like 2, or LOXL2. Its product candidate GB0139 is for the treatment of severe fibrotic lung diseases such as idiopathic pulmonary fibrosis, or IPF, a life-threatening progressive fibrotic disease of the lung. Its product GB1211, a selective oral galectin-3 inhibitor for the treatment of fibrosis related to non-alcoholic steatohepatitis, or NASH, and GB2064, a selective oral inhibitor of LOXL2 that it initially plans to develop for the treatment of myelofibrosis.

Share on Social Networks: